truncated pDAG peptide (Therimunex)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametruncated pDAG peptide (Therimunex)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCytokine release inhibitorsImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTherimunex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherimunex
Active IndicationsN/A
Inactive IndicationsScleroderma, Systemic

Other Information

ATC CodeN/A
Related LinksN/A